Lucia Lavalle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lucia Lavalle has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- David Moreno-Martínez
Lysosomal Storage Disorders Unit Royal Free Hospital NHS Foundation Trust and University College London London UK
2 shared publications - Derralynn A. Hughes
Lysosomal Storage Disorders Unit, Royal Free London NHS Foundation Trust and University College London
2 shared publications - Guillem Pintos-Morell
Clinical Biochemistry Drug Delivery and Therapy Group (CB-DDT), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona 08035, Spain
1 shared publication - Hibba Kurdi
Cardiology Research Fellow
1 shared publication - Lionel Ginsberg
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology , London NW3 2PF
1 shared publication - Sara Lucas Del Pozo
Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London (UCL), London, UK
1 shared publication
Latest Publications
- Open Access
- 14 March 2026
- Published by Elsevier in SSRN Electronic Journal
Mitochondrial Unfolded Protein Response Activation Associates with Phenotypes in Fabry Disease
Background: Fabry disease (FD) exhibits marked clinical heterogeneity that cannot be fully explained by residual α-galactosidase A activity. Mitochondrial dysfunction has been reported in FD, but the role of mitochondrial stress remains unexplored.Objective: To investigate whether activation of the mitochondrial unfolded protein response contributes to phenotypic variability and correlates with disease severity.Methods: We measured intracellular heat-shock protein 60 (Hsp60) by western blotting in peripheral blood mononuclear cells from 27 FD patients (14 males, 13 females). Serum fibroblast growth-factor-21 and growth differentiation-factor-15 were measured in 35 patients. Clinical outcomes included Mainz Severity Score Index, Age-Adjusting Severity Score, estimated glomerular filtration rate, and left-ventricular mass index (LVMI).Results: Hsp60 showed variability, with sex-specific associations. In males, higher Hsp60 correlated with lower LVMI (r²=-0.82, p=0.01) and preserved renal function in late-onset patients (r²=0.89, p=0.006). In females, higher Hsp60 associated with higher LVMI (r²=0.66, p=0.045) and greater clinical severity. Male patients had elevated growth differentiation-factor-15 vs controls (935 vs 559 pg/ml, p=0.002). Both mitokines correlated with age and disease severity.Conclusions: mitochondrial unfolded protein response activation exhibits sex- and genotype-specific patterns associated with disease severity, suggesting that mitochondrial stress contributes to phenotypic heterogeneity and may serve as biomarkers for treatment optimisation.
- 14 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMitochondrial Unfolded Protein Response Activation Associates with Phenotypes in Fabry Disease
Background: Fabry disease (FD) exhibits marked clinical heterogeneity that cannot be fully explained by residual α-galactosidase A activity. Mitochondrial dysfunction has been reported in FD, but the role of mitochondrial stress remains unexplored.Objective: To investigate whether activation of the mitochondrial unfolded protein response contributes to phenotypic variability and correlates with disease severity.Methods: We measured intracellular heat-shock protein 60 (Hsp60) by western blotting in peripheral blood mononuclear cells from 27 FD patients (14 males, 13 females). Serum fibroblast growth-factor-21 and growth differentiation-factor-15 were measured in 35 patients. Clinical outcomes included Mainz Severity Score Index, Age-Adjusting Severity Score, estimated glomerular filtration rate, and left-ventricular mass index (LVMI).Results: Hsp60 showed variability, with sex-specific associations. In males, higher Hsp60 correlated with lower LVMI (r²=-0.82, p=0.01) and preserved renal function in late-onset patients (r²=0.89, p=0.006). In females, higher Hsp60 associated with higher LVMI (r²=0.66, p=0.045) and greater clinical severity. Male patients had elevated growth differentiation-factor-15 vs controls (935 vs 559 pg/ml, p=0.002). Both mitokines correlated with age and disease severity.Conclusions: mitochondrial unfolded protein response activation exhibits sex- and genotype-specific patterns associated with disease severity, suggesting that mitochondrial stress contributes to phenotypic heterogeneity and may serve as biomarkers for treatment optimisation.
- Open Access
- 7 November 2025
- Published by Wiley in European Journal of Neurology
- Vol. 32 (11) , e70415
Stroke in Fabry Disease: Identification of Risk Factors for Stroke in a Large Single‐Centre Cohort
Objectives: Risk factors for stroke in Fabry disease (FD) are not precisely known. This study presents a retrospective cohort analysis from one reference centre in the United Kingdom to determine risk factors for stroke and to develop a predictive model. Methods: Patients > 18 years old were included in the study and were followed from their first visit until March 2019. The main outcome of the survival analysis was time to stroke. The independent risk factors were evaluated using a multivariate Cox regression. Results: Of 414 patients, 368 were included in the survival analysis. 227 (61.7%) were female, with a median baseline age of 42.7 (IQR 27.8–54.8) for males and 39.9 (26.6–51.2) years for females. 56 (39.7%) males and 64 (28.2%) females had the N215S genotype. 41 patients had a stroke at baseline (11.2%), rising to 69 (18.8%) at the end—66.7% lacunar, 18.9% anterior circulation, 13% posterior circulation and 1.4% venous thrombosis. Median follow‐up was 10.4 years. Median time to stroke in males and females was 43 (43–43) and 58 (58–59) years, respectively. In the multivariate analysis, a concomitant autoimmune disease was associated with an increased risk of stroke, while glomerular filtration rate > 90 and N215S genotype were associated with a decreased risk. Interpretation: Sex was not associated with stroke, despite males being more severe. These results might help stratify patients and are of interest not only to metabolic physicians, but to general stroke physicians too.
- 7 November 2025
- Published by Wiley in European Journal of Neurology
- Vol. 32 (11) , e70415
Open AccessStroke in Fabry Disease: Identification of Risk Factors for Stroke in a Large Single‐Centre Cohort
Objectives: Risk factors for stroke in Fabry disease (FD) are not precisely known. This study presents a retrospective cohort analysis from one reference centre in the United Kingdom to determine risk factors for stroke and to develop a predictive model. Methods: Patients > 18 years old were included in the study and were followed from their first visit until March 2019. The main outcome of the survival analysis was time to stroke. The independent risk factors were evaluated using a multivariate Cox regression. Results: Of 414 patients, 368 were included in the survival analysis. 227 (61.7%) were female, with a median baseline age of 42.7 (IQR 27.8–54.8) for males and 39.9 (26.6–51.2) years for females. 56 (39.7%) males and 64 (28.2%) females had the N215S genotype. 41 patients had a stroke at baseline (11.2%), rising to 69 (18.8%) at the end—66.7% lacunar, 18.9% anterior circulation, 13% posterior circulation and 1.4% venous thrombosis. Median follow‐up was 10.4 years. Median time to stroke in males and females was 43 (43–43) and 58 (58–59) years, respectively. In the multivariate analysis, a concomitant autoimmune disease was associated with an increased risk of stroke, while glomerular filtration rate > 90 and N215S genotype were associated with a decreased risk. Interpretation: Sex was not associated with stroke, despite males being more severe. These results might help stratify patients and are of interest not only to metabolic physicians, but to general stroke physicians too.